| |
|
|
|
Antares Pharma Inc.  
|
|
2.6 0.02 (0.01%) |
07-10 16:00 |
|
Open: |
2.59 |
Pre close: |
2.58 |
Target:
|
3.47 
|
|
High: |
2.615 |
Low: |
2.53 |
Resistance:
|
2.97
3.24
|
|
Volume: |
579,674 |
Market Cap: |
430M |
Support:
|
2.53
2.10
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.67
|
MACD |
MACD(12,26):
|
-0.06 |
|
MA(20): |
2.78 |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
2.77 |
Stochastic Oscillator |
%K(14,3):
|
12.62 |
|
MA(250): |
3.38 |
%D(3): |
17.42 |
|
Average Volume(K) |
3-Month: |
124514
|
52-Week |
High:
|
5.13 |
|
10-Days: |
97530 |
Low: |
1.60 |
|
RSI |
RSI(14):
|
39.99  |
Change(%): |
-14.5 |
|
Financials, Statistics and Valuation |
|
EPS |
0.007 |
Return on Equity (ttm) |
2.4 |
Shares Out. (M) |
165.56 |
|
EPS Est. Current Year |
-0.100 |
Return on Assets (ttm) |
2.4 |
Shares Float (M) |
152.86 |
|
EPS Est. Next Year |
0.010 |
PEG Ratio |
0.00 |
% Held by Insiders |
7.45 |
|
EPS Est. Next Quarter |
-0.030 |
Qtrly Rev. Growth |
42.1 |
% Held by Institutions |
41.63 |
|
Forward EPS |
-0.010 |
Gross Profit (p.s.) |
0.443 |
Shares Short (K) |
4660 |
|
Book Value (p.s.) |
0.320 |
EBITDA (p.s.) |
0.043 |
P/E |
371.43 |
|
Sales Per Share |
0.807 |
Qtrly Earnings Growth |
0.00 |
P/BV |
8.13 |
|
Profit Margin |
0.87 |
Operating Cash Flow
(M) |
6.96 |
P/S |
3.22 |
|
Operating Margin |
3.44 |
Levered Free Cash Flow
(M) |
8.55 |
P/CF |
61.85 |
|
|
|
|
|
|
